Initiate Consultancy
A full-service Market Access and Health Economics & Outcomes Research (HEOR) consultancy.
Investment date: December 2025
Visit siteOverview
Initiate is a full-service Market Access and Health Economics & Outcomes Research (HEOR) consultancy based in the UK. The business supports pharma and biotech companies to secure reimbursement and pricing approval so that drugs can be launched in new markets and paid for by healthcare systems, providing strategic advice to clients, producing collateral to support pricing and access globally, and offering hands-on support with specific country-level submissions.
“Partnering with QPE represents a pivotal moment for Initiate. Their deep sector expertise and operational support will enable us to further elevate our service offering and expand our global footprint. Together, we are well positioned to deliver even more impactful access solutions for our clients.”
Andrew Mumford
Initiate CEO
Strategy
The QPE investment will be used to help Initiate extend its global reach and broaden its service offering while preserving its autonomy, values, and commitment to quality. Growth will be both organic and through making carefully selected acquisitions.
“Initiate Consultancy exemplifies everything we seek in an entrepreneur-led company: deep domain expertise, a clear value-creation strategy, and a client-first mindset. We firmly believe that as the demand for robust market access and evidence services grows, Initiate is well-positioned to become a market leader. We are excited to support Andrew and the team on their next phase of accelerated growth.”
Mark Crowley
Investing, QPE
